Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2004 Oct;75(10):1376–1381. doi: 10.1136/jnnp.2004.045690

The natural history of epilepsy: an epidemiological view

P Kwan 1, J Sander 1
PMCID: PMC1738749  PMID: 15377680

Abstract

Better information of the natural history of epilepsy has important implications for understanding the underlying neurobiology, evaluating treatment strategies, and planning healthcare resources. The traditional pessimistic view has been dispelled by results from modern community based prospective studies, showing that over 60% of newly diagnosed patients will enter remission upon treatment. Recent outcome studies suggest that medical intractability may be predicted after failure of two antiepileptic drugs. Poor prognostic factors include a high initial seizure density, symptomatic aetiology, and presence of structural cerebral abnormalities, all of which can be identified early on. Among patients who have entered remission, many will remain seizure-free after antiepileptic drug treatment is withdrawn, suggesting that the underlying seizure generating factor has remitted. Whether some of these patients have entered remission "spontaneously" is contentious because, with effective pharmacotherapy for epilepsy in use for over 100 years, the natural history of untreated epilepsy is largely unknown. Circumstantial evidence, mostly arising from resource poor countries where antiepileptic drug treatment is not readily available, indicates that spontaneous remission may occur in up to 30% of cases. Observations from these complementary sources suggest that, at the population level, prognosis of newly diagnosed epilepsy may be broadly categorised into three groups: remission without treatment, remission with treatment only, and persistent seizures despite treatment. As understanding of the prognostic factors improves, the potential of a "prognostic group specific" management approach should be explored so that effective treatments may be used in a more rational and targeted fashion.

Full Text

The Full Text of this article is available as a PDF (82.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Annegers J. F., Hauser W. A., Elveback L. R. Remission of seizures and relapse in patients with epilepsy. Epilepsia. 1979 Dec;20(6):729–737. doi: 10.1111/j.1528-1157.1979.tb04857.x. [DOI] [PubMed] [Google Scholar]
  2. Annegers J. F., Rocca W. A., Hauser W. A. Causes of epilepsy: contributions of the Rochester epidemiology project. Mayo Clin Proc. 1996 Jun;71(6):570–575. doi: 10.4065/71.6.570. [DOI] [PubMed] [Google Scholar]
  3. Berg A. T., Langfitt J., Shinnar S., Vickrey B. G., Sperling M. R., Walczak T., Bazil C., Pacia S. V., Spencer S. S. How long does it take for partial epilepsy to become intractable? Neurology. 2003 Jan 28;60(2):186–190. doi: 10.1212/01.wnl.0000031792.89992.ec. [DOI] [PubMed] [Google Scholar]
  4. Berg A. T., Shinnar S. Do seizures beget seizures? An assessment of the clinical evidence in humans. J Clin Neurophysiol. 1997 Mar;14(2):102–110. doi: 10.1097/00004691-199703000-00003. [DOI] [PubMed] [Google Scholar]
  5. Berg A. T., Shinnar S. Relapse following discontinuation of antiepileptic drugs: a meta-analysis. Neurology. 1994 Apr;44(4):601–608. doi: 10.1212/wnl.44.4.601. [DOI] [PubMed] [Google Scholar]
  6. Britton Jeffrey W. Antiepileptic drug withdrawal: literature review. Mayo Clin Proc. 2002 Dec;77(12):1378–1388. doi: 10.4065/77.12.1378. [DOI] [PubMed] [Google Scholar]
  7. Brodie M. J., Dichter M. A. Antiepileptic drugs. N Engl J Med. 1996 Jan 18;334(3):168–175. doi: 10.1056/NEJM199601183340308. [DOI] [PubMed] [Google Scholar]
  8. Brodie M. J., Kwan P. The star systems: overview and use in determining antiepileptic drug choice. CNS Drugs. 2001 Jan;15(1):1–15. doi: 10.2165/00023210-200115010-00001. [DOI] [PubMed] [Google Scholar]
  9. Brodie Martin J., Kwan Patrick. Staged approach to epilepsy management. Neurology. 2002 Apr 23;58(8 Suppl 5):S2–S8. doi: 10.1212/wnl.58.8_suppl_5.s2. [DOI] [PubMed] [Google Scholar]
  10. Camfield C., Camfield P., Gordon K., Dooley J. Does the number of seizures before treatment influence ease of control or remission of childhood epilepsy? Not if the number is 10 or less. Neurology. 1996 Jan;46(1):41–44. doi: 10.1212/wnl.46.1.41. [DOI] [PubMed] [Google Scholar]
  11. Cockerell O. C., Johnson A. L., Sander J. W., Hart Y. M., Shorvon S. D. Remission of epilepsy: results from the National General Practice Study of Epilepsy. Lancet. 1995 Jul 15;346(8968):140–144. doi: 10.1016/s0140-6736(95)91208-8. [DOI] [PubMed] [Google Scholar]
  12. Cockerell O. C., Johnson A. L., Sander J. W., Shorvon S. D. Prognosis of epilepsy: a review and further analysis of the first nine years of the British National General Practice Study of Epilepsy, a prospective population-based study. Epilepsia. 1997 Jan;38(1):31–46. doi: 10.1111/j.1528-1157.1997.tb01075.x. [DOI] [PubMed] [Google Scholar]
  13. Dlugos D. J., Sammel M. D., Strom B. L., Farrar J. T. Response to first drug trial predicts outcome in childhood temporal lobe epilepsy. Neurology. 2001 Dec 26;57(12):2259–2264. doi: 10.1212/wnl.57.12.2259. [DOI] [PubMed] [Google Scholar]
  14. Duncan John S. Seizure-induced neuronal injury: human data. Neurology. 2002 Nov 12;59(9 Suppl 5):S15–S20. doi: 10.1212/wnl.59.9_suppl_5.s15. [DOI] [PubMed] [Google Scholar]
  15. Elwes R. D., Johnson A. L., Shorvon S. D., Reynolds E. H. The prognosis for seizure control in newly diagnosed epilepsy. N Engl J Med. 1984 Oct 11;311(15):944–947. doi: 10.1056/NEJM198410113111503. [DOI] [PubMed] [Google Scholar]
  16. Feksi A. T., Kaamugisha J., Sander J. W., Gatiti S., Shorvon S. D. Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya. ICBERG (International Community-based Epilepsy Research Group) Lancet. 1991 Feb 16;337(8738):406–409. doi: 10.1016/0140-6736(91)91176-u. [DOI] [PubMed] [Google Scholar]
  17. Foy P. M., Chadwick D. W., Rajgopalan N., Johnson A. L., Shaw M. D. Do prophylactic anticonvulsant drugs alter the pattern of seizures after craniotomy? J Neurol Neurosurg Psychiatry. 1992 Sep;55(9):753–757. doi: 10.1136/jnnp.55.9.753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Fuerst Darren, Shah Jagdish, Shah Aashit, Watson Craig. Hippocampal sclerosis is a progressive disorder: a longitudinal volumetric MRI study. Ann Neurol. 2003 Mar;53(3):413–416. doi: 10.1002/ana.10509. [DOI] [PubMed] [Google Scholar]
  19. Hart Y. M., Sander J. W., Johnson A. L., Shorvon S. D. National General Practice Study of Epilepsy: recurrence after a first seizure. Lancet. 1990 Nov 24;336(8726):1271–1274. doi: 10.1016/0140-6736(90)92960-p. [DOI] [PubMed] [Google Scholar]
  20. Hart Y. M., Sander J. W., Sharvon S. D. National General Practice Study of Epilepsy and Epileptic Seizures: objectives and study methodology of the largest reported prospective cohort study of epilepsy. National General Practice Study of Epilepsy and Epileptic Seizures (NGPSE). Neuroepidemiology. 1989;8(5):221–227. doi: 10.1159/000110186. [DOI] [PubMed] [Google Scholar]
  21. Hauser W. A., Annegers J. F., Kurland L. T. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia. 1993 May-Jun;34(3):453–468. doi: 10.1111/j.1528-1157.1993.tb02586.x. [DOI] [PubMed] [Google Scholar]
  22. Hauser W. A., Annegers J. F., Kurland L. T. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia. 1991 Jul-Aug;32(4):429–445. doi: 10.1111/j.1528-1157.1991.tb04675.x. [DOI] [PubMed] [Google Scholar]
  23. Hauser W. A., Annegers J. F., Rocca W. A. Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota. Mayo Clin Proc. 1996 Jun;71(6):576–586. doi: 10.4065/71.6.576. [DOI] [PubMed] [Google Scholar]
  24. Hauser W. A., Kurland L. T. The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia. 1975 Mar;16(1):1–66. doi: 10.1111/j.1528-1157.1975.tb04721.x. [DOI] [PubMed] [Google Scholar]
  25. Holmes Gregory L. Seizure-induced neuronal injury: animal data. Neurology. 2002 Nov 12;59(9 Suppl 5):S3–S6. doi: 10.1212/wnl.59.9_suppl_5.s3. [DOI] [PubMed] [Google Scholar]
  26. Kale Rajendra. Global Campaign Against Epilepsy:the treatment gap. Epilepsia. 2002;43 (Suppl 6):31–33. doi: 10.1046/j.1528-1157.43.s.6.13.x. [DOI] [PubMed] [Google Scholar]
  27. Keränen T., Riekkinen P. J. Remission of seizures in untreated epilepsy. BMJ. 1993 Aug 21;307(6902):483–483. doi: 10.1136/bmj.307.6902.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kobayashi E., Lopes-Cendes I., Guerreiro C. A., Sousa S. C., Guerreiro M. M., Cendes F. Seizure outcome and hippocampal atrophy in familial mesial temporal lobe epilepsy. Neurology. 2001 Jan 23;56(2):166–172. doi: 10.1212/wnl.56.2.166. [DOI] [PubMed] [Google Scholar]
  29. Kwan P., Brodie M. J. Early identification of refractory epilepsy. N Engl J Med. 2000 Feb 3;342(5):314–319. doi: 10.1056/NEJM200002033420503. [DOI] [PubMed] [Google Scholar]
  30. Kwan P., Brodie M. J. Effectiveness of first antiepileptic drug. Epilepsia. 2001 Oct;42(10):1255–1260. doi: 10.1046/j.1528-1157.2001.04501.x. [DOI] [PubMed] [Google Scholar]
  31. Kwan Patrick, Brodie Martin J. Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy. Neurology. 2003 Jun 10;60(11 Suppl 4):S2–12. doi: 10.1212/wnl.60.11_suppl_4.s2. [DOI] [PubMed] [Google Scholar]
  32. Kwan Patrick, Brodie Martin J. Drug treatment of epilepsy: when does it fail and how to optimize its use? CNS Spectr. 2004 Feb;9(2):110–119. doi: 10.1017/s1092852900008476. [DOI] [PubMed] [Google Scholar]
  33. Lindsten H., Stenlund H., Forsgren L. Remission of seizures in a population-based adult cohort with a newly diagnosed unprovoked epileptic seizure. Epilepsia. 2001 Aug;42(8):1025–1030. doi: 10.1046/j.1528-1157.2001.0420081025.x. [DOI] [PubMed] [Google Scholar]
  34. Löscher W., Hönack D., Rundfeldt C. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy. J Pharmacol Exp Ther. 1998 Feb;284(2):474–479. [PubMed] [Google Scholar]
  35. MacDonald B. K., Johnson A. L., Goodridge D. M., Cockerell O. C., Sander J. W., Shorvon S. D. Factors predicting prognosis of epilepsy after presentation with seizures. Ann Neurol. 2000 Dec;48(6):833–841. [PubMed] [Google Scholar]
  36. Mattson R. H., Cramer J. A., Collins J. F. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. N Engl J Med. 1992 Sep 10;327(11):765–771. doi: 10.1056/NEJM199209103271104. [DOI] [PubMed] [Google Scholar]
  37. Mattson R. H., Cramer J. A., Collins J. F., Smith D. B., Delgado-Escueta A. V., Browne T. R., Williamson P. D., Treiman D. M., McNamara J. O., McCutchen C. B. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med. 1985 Jul 18;313(3):145–151. doi: 10.1056/NEJM198507183130303. [DOI] [PubMed] [Google Scholar]
  38. Meinardi H., Scott R. A., Reis R., Sander J. W., ILAE Commission on the Developing World The treatment gap in epilepsy: the current situation and ways forward. Epilepsia. 2001 Jan;42(1):136–149. doi: 10.1046/j.1528-1157.2001.32800.x. [DOI] [PubMed] [Google Scholar]
  39. Musicco M., Beghi E., Solari A., Viani F. Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy. First Seizure Trial Group (FIRST Group). Neurology. 1997 Oct;49(4):991–998. doi: 10.1212/wnl.49.4.991. [DOI] [PubMed] [Google Scholar]
  40. Peters A. C., Brouwer O. F., Geerts A. T., Arts W. F., Stroink H., van Donselaar C. A. Randomized prospective study of early discontinuation of antiepileptic drugs in children with epilepsy. Neurology. 1998 Mar;50(3):724–730. doi: 10.1212/wnl.50.3.724. [DOI] [PubMed] [Google Scholar]
  41. Pitkänen Asla. Drug-mediated neuroprotection and antiepileptogenesis: animal data. Neurology. 2002 Nov 12;59(9 Suppl 5):S27–S33. doi: 10.1212/wnl.59.9_suppl_5.s27. [DOI] [PubMed] [Google Scholar]
  42. Placencia M., Sander J. W., Roman M., Madera A., Crespo F., Cascante S., Shorvon S. D. The characteristics of epilepsy in a largely untreated population in rural Ecuador. J Neurol Neurosurg Psychiatry. 1994 Mar;57(3):320–325. doi: 10.1136/jnnp.57.3.320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Placencia M., Shorvon S. D., Paredes V., Bimos C., Sander J. W., Suarez J., Cascante S. M. Epileptic seizures in an Andean region of Ecuador. Incidence and prevalence and regional variation. Brain. 1992 Jun;115(Pt 3):771–782. doi: 10.1093/brain/115.3.771. [DOI] [PubMed] [Google Scholar]
  44. Regesta G., Tanganelli P. Clinical aspects and biological bases of drug-resistant epilepsies. Epilepsy Res. 1999 Apr;34(2-3):109–122. doi: 10.1016/s0920-1211(98)00106-5. [DOI] [PubMed] [Google Scholar]
  45. Rosman N. P., Colton T., Labazzo J., Gilbert P. L., Gardella N. B., Kaye E. M., Van Bennekom C., Winter M. R. A controlled trial of diazepam administered during febrile illnesses to prevent recurrence of febrile seizures. N Engl J Med. 1993 Jul 8;329(2):79–84. doi: 10.1056/NEJM199307083290202. [DOI] [PubMed] [Google Scholar]
  46. Sander J. W., Hart Y. M., Johnson A. L., Shorvon S. D. National General Practice Study of Epilepsy: newly diagnosed epileptic seizures in a general population. Lancet. 1990 Nov 24;336(8726):1267–1271. doi: 10.1016/0140-6736(90)92959-l. [DOI] [PubMed] [Google Scholar]
  47. Sander J. W., Shorvon S. D. Epidemiology of the epilepsies. J Neurol Neurosurg Psychiatry. 1996 Nov;61(5):433–443. doi: 10.1136/jnnp.61.5.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Sander J. W. Some aspects of prognosis in the epilepsies: a review. Epilepsia. 1993 Nov-Dec;34(6):1007–1016. doi: 10.1111/j.1528-1157.1993.tb02126.x. [DOI] [PubMed] [Google Scholar]
  49. Schachter Steven C. Current evidence indicates that antiepileptic drugs are anti-ictal, not antiepileptic. Epilepsy Res. 2002 Jun;50(1-2):67–70. doi: 10.1016/s0920-1211(02)00069-4. [DOI] [PubMed] [Google Scholar]
  50. Scott R. A., Lhatoo S. D., Sander J. W. The treatment of epilepsy in developing countries: where do we go from here? Bull World Health Organ. 2003 Jul 2;79(4):344–351. [PMC free article] [PubMed] [Google Scholar]
  51. Semah F., Picot M. C., Adam C., Broglin D., Arzimanoglou A., Bazin B., Cavalcanti D., Baulac M. Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology. 1998 Nov;51(5):1256–1262. doi: 10.1212/wnl.51.5.1256. [DOI] [PubMed] [Google Scholar]
  52. Shafer S. Q., Hauser W. A., Annegers J. F., Klass D. W. EEG and other early predictors of epilepsy remission: a community study. Epilepsia. 1988 Sep-Oct;29(5):590–600. doi: 10.1111/j.1528-1157.1988.tb03767.x. [DOI] [PubMed] [Google Scholar]
  53. Siddiqui Asra, Kerb Reinhold, Weale Michael E., Brinkmann Ulrich, Smith Alice, Goldstein David B., Wood Nicholas W., Sisodiya Sanjay M. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med. 2003 Apr 10;348(15):1442–1448. doi: 10.1056/NEJMoa021986. [DOI] [PubMed] [Google Scholar]
  54. Sillanpä M., Jalava M., Kaleva O., Shinnar S. Long-term prognosis of seizures with onset in childhood. N Engl J Med. 1998 Jun 11;338(24):1715–1722. doi: 10.1056/NEJM199806113382402. [DOI] [PubMed] [Google Scholar]
  55. Temkin N. R. Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia. 2001 Apr;42(4):515–524. doi: 10.1046/j.1528-1157.2001.28900.x. [DOI] [PubMed] [Google Scholar]
  56. Temkin N. R., Dikmen S. S., Anderson G. D., Wilensky A. J., Holmes M. D., Cohen W., Newell D. W., Nelson P., Awan A., Winn H. R. Valproate therapy for prevention of posttraumatic seizures: a randomized trial. J Neurosurg. 1999 Oct;91(4):593–600. doi: 10.3171/jns.1999.91.4.0593. [DOI] [PubMed] [Google Scholar]
  57. Temkin N. R., Dikmen S. S., Wilensky A. J., Keihm J., Chabal S., Winn H. R. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med. 1990 Aug 23;323(8):497–502. doi: 10.1056/NEJM199008233230801. [DOI] [PubMed] [Google Scholar]
  58. Walz R., Castro R. M. R. P. S., Velasco T. R., Alexandre V., Jr, Lopes M. H., Leite J. P., Santos A. C., Assirati J. A., Jr, Wichert-Ana L., Terra-Bustamante V. C. Surgical outcome in mesial temporal sclerosis correlates with prion protein gene variant. Neurology. 2003 Nov 11;61(9):1204–1210. doi: 10.1212/01.wnl.0000096940.92986.02. [DOI] [PubMed] [Google Scholar]
  59. Wang W. Z., Wu J. Z., Wang D. S., Dai X. Y., Yang B., Wang T. P., Yuan C. L., Scott R. A., Prilipko L. L., de Boer H. M. The prevalence and treatment gap in epilepsy in China: an ILAE/IBE/WHO study. Neurology. 2003 May 13;60(9):1544–1545. doi: 10.1212/01.wnl.0000059867.35547.de. [DOI] [PubMed] [Google Scholar]
  60. Wolf S. M., Forsythe A. Epilepsy and mental retardation following febrile seizures in childhood. Acta Paediatr Scand. 1989 Mar;78(2):291–295. doi: 10.1111/j.1651-2227.1989.tb11072.x. [DOI] [PubMed] [Google Scholar]
  61. Zarrelli M. M., Beghi E., Rocca W. A., Hauser W. A. Incidence of epileptic syndromes in Rochester, Minnesota: 1980-1984. Epilepsia. 1999 Dec;40(12):1708–1714. doi: 10.1111/j.1528-1157.1999.tb01587.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES